NEUROPHARMAGEN
Live / Allowed — Notice of allowance issued (as of 31 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98671767
- Mark type
- Word mark
- Filed
- 29 Jul 2024
- Published for opposition
- 03 Feb 2026
- Attorney of record
- Michelle E. Tochtrop
Goods and services
- Class 042 — Scientific and technological services: Software as a service (SAAS) featuring software for analyzing, accessing, and storing information and making recommendations to users in the field of pharmacogenetics; Platform as a Service (PAAS) featuring computer platforms for analyzing, accessing, storing information and making recommendations to users in the field of pharmacogenetics; Science and technology services, namely analysis in the field of pharmacogenetics; Genetic research; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Medical and pharmacological research services; Design and development of medical technology; Design and development of computer software for use with medical technology; Pharmaceutical products development; Research laboratory analysis in the field of genetics; Scientific research in the nature of conducting clinical trials for others; Structural and functional analysis of genomes; Research in the field of pharmacogenetics; Information, advice and consultancy regarding all aforementioned services
- Class 044 — Medical, beauty and agricultural services: Medical services; Medical diagnostic services; Medical analysis services for the treatment of persons; Genetic testing for medical purposes; Performing diagnosis of diseases; Medical analysis for the diagnosis and treatment of persons; Remote monitoring of medical data for medical diagnosis and treatment; Genetic analysis in order to increase the efficiency of treatments for patients for medical purposes; Services for the preparation of medical reports, namely, providing information to medical professionals in the form of reports in the field of pharmacogenetics; Information, advice and consultancy regarding all aforementioned services
Owner
- PRECISION MOLECULAR SOLUTIONS LLC, Charleston, SC, US
- PRECISION MOLECULAR SOLUTIONS LLC, Charleston, SC, US
Prior registrations
Prosecution history
- 31 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Feb 2026 — PUBLISHED FOR OPPOSITION
- 28 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Aug 2025 — NON-FINAL ACTION E-MAILED
- 23 Aug 2025 — NON-FINAL ACTION WRITTEN
- 17 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Jul 2025 — ASSIGNED TO LIE
- 02 Jul 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED